{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:12:42Z","timestamp":1779937962796,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-020-0190-5","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T13:02:53Z","timestamp":1592312573000},"page":"356-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Predicting tumour mutational burden from histopathological images using multiscale deep learning"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-0874","authenticated-orcid":false,"given":"Mika S.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-1408","authenticated-orcid":false,"given":"Tarik F.","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"190_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"E Garon","year":"2015","unstructured":"Garon, E. et al. Pembrolizumab for the treatment of non-small cell lung cancer. N. Engl. J. Med. 372, 2018\u20132028 (2015).","journal-title":"N. Engl. J. Med."},{"key":"190_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"D Pardoll","year":"2012","unstructured":"Pardoll, D. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"190_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(15)70054-9","volume":"16","author":"N Rizvi","year":"2015","unstructured":"Rizvi, N. et al. Activity and safety of nivolumab and an anti-PD-1 immune checkpoint inhibitor and for patients with advanced and refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 16, 257\u2013265 (2015).","journal-title":"Lancet Oncol."},{"key":"190_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"T Chan","year":"2018","unstructured":"Chan, T. et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann. Oncol. 30, 44\u201356 (2018).","journal-title":"Ann. Oncol."},{"key":"190_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","volume":"24","author":"D Gandara","year":"2018","unstructured":"Gandara, D. et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nat. Med. 24, 1441\u20131448 (2018).","journal-title":"Nat. Med."},{"key":"190_CR6","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"M Goodman","year":"2017","unstructured":"Goodman, M. et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol. Cancer Ther. 16, 2598\u20132608 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"190_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"R Samstein","year":"2019","unstructured":"Samstein, R. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"key":"190_CR8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","volume":"378","author":"M Hellmann","year":"2018","unstructured":"Hellmann, M. et al. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. N. Engl. J. Med. 378, 2093\u20132104 (2018).","journal-title":"N. Engl. J. Med."},{"key":"190_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1200\/JCO.2017.76.8770","volume":"36","author":"C Steuer","year":"2018","unstructured":"Steuer, C. & Ramalingam, S. Tumor mutation burden: leading immunotherapy to the era of precision medicine? J. Clin. Oncol. 36, 631\u2013632 (2018).","journal-title":"J. Clin. Oncol."},{"key":"190_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"Z Chalmers","year":"2017","unstructured":"Chalmers, Z. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9, 34 (2017).","journal-title":"Genome Med."},{"key":"190_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ijc.31878","volume":"144","author":"I Buchhalter","year":"2019","unstructured":"Buchhalter, I. et al. Size matters: dissecting key parameters for panel-based tumor mutational burden analysis. Int. J. Cancer 144, 848\u2013858 (2019).","journal-title":"Int. J. Cancer"},{"key":"190_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"A Carpenter","year":"2006","unstructured":"Carpenter, A. et al. Cellprofiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"190_CR13","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin, C. et al. Cellprofiler 3.0: next-generation image processing for biology. Genome Biol. 16, e2005970 (2018).","journal-title":"Genome Biol."},{"key":"190_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cels.2017.10.014","volume":"5","author":"K Yu","year":"2017","unstructured":"Yu, K. et al. Association of omics features with histopathology patterns in lung adenocarcinoma. Cell Syst. 5, 620\u2013627 (2017).","journal-title":"Cell Syst."},{"key":"190_CR15","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1038\/ncomms12474","volume":"7","author":"K Yu","year":"2016","unstructured":"Yu, K. et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat. Commun. 7, 12474 (2016).","journal-title":"Nat. Commun."},{"key":"190_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"190_CR17","first-page":"2199","volume":"318","author":"B Ehteshami","year":"2017","unstructured":"Ehteshami, B. et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. Genome Biol. 318, 2199\u20132210 (2017).","journal-title":"Genome Biol."},{"key":"190_CR18","doi-asserted-by":"publisher","first-page":"e0177544","DOI":"10.1371\/journal.pone.0177544","volume":"12","author":"T Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo, T. et al. Classification of breast cancer histology images using convolutional neural networks. PLoS ONE 12, e0177544 (2017).","journal-title":"PLoS ONE"},{"key":"190_CR19","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","volume":"24","author":"N Coudray","year":"2018","unstructured":"Coudray, N. et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat. Med. 24, 1559\u20131567 (2018).","journal-title":"Nat. Med."},{"key":"190_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2017.12.026","volume":"27","author":"P Khosravi","year":"2018","unstructured":"Khosravi, P., Kazemi, E., Imielinski, M., Elemento, O. & Hajirasouliha, I. Deep convolutional neural networks enable discrimination of heterogeneous digital pathology images. EBioMedicine 27, 317\u2013328 (2018).","journal-title":"EBioMedicine"},{"key":"190_CR21","doi-asserted-by":"crossref","unstructured":"Szegedy, C., Vanhoucke, V., Ioffe, S., Shlens, J. & Wojna, Z. Rethinking the inception architecture for computer vision. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (IEEE, 2016); preprint at https:\/\/arxiv.org\/abs\/1512.00567.","DOI":"10.1109\/CVPR.2016.308"},{"key":"190_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11263-015-0816-y","volume":"115","author":"O Russakovsky","year":"2015","unstructured":"Russakovsky, O. et al. ImageNet large scale visual recognition challenge. Int. J. Comput. Vis. 115, 211\u2013252 (2015).","journal-title":"Int. J. Comput. Vis."},{"key":"190_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","volume":"33","author":"M Hellmann","year":"2018","unstructured":"Hellmann, M. et al. Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer. Cancer Cell 33, 843\u2013852 (2018).","journal-title":"Cancer Cell"},{"key":"190_CR24","doi-asserted-by":"publisher","first-page":"73098","DOI":"10.18632\/oncotarget.20392","volume":"8","author":"J Kim","year":"2017","unstructured":"Kim, J., Kim, H., Kim, B., Lee, J. & Jang, H. Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a metaanalysis. Oncotarget 8, 73098\u201373104 (2017).","journal-title":"Oncotarget"},{"key":"190_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/1078-0432.CCR-18-1102","volume":"25","author":"M Offin","year":"2019","unstructured":"Offin, M. et al. Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers. Clin. Cancer Res. 25, 1063\u20131069 (2019).","journal-title":"Clin. Cancer Res."},{"key":"190_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"D Koboldt","year":"2012","unstructured":"Koboldt, D. et al. Varscan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-020-0190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-020-0190-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-020-0190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:47:07Z","timestamp":1670366827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-020-0190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1038\/s42256-020-0190-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.15.153379","asserted-by":"object"}]},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}